292 related articles for article (PubMed ID: 23619104)
1. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
Gleeson M; Meiser B; Barlow-Stewart K; Trainer AH; Tucker K; Watts KJ; Friedlander M; Kasparian N
Oncol Nurs Forum; 2013 May; 40(3):275-83. PubMed ID: 23619104
[TBL] [Abstract][Full Text] [Related]
2. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
[TBL] [Abstract][Full Text] [Related]
3. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
Meiser B; Gleeson M; Kasparian N; Barlow-Stewart K; Ryan M; Watts K; Menon D; Mitchell G; Tucker K
Gynecol Oncol; 2012 Jan; 124(1):153-7. PubMed ID: 22032838
[TBL] [Abstract][Full Text] [Related]
4. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer survivors: qualitative analysis of the symptom of sexuality.
Wilmoth MC; Hatmaker-Flanigan E; LaLoggia V; Nixon T
Oncol Nurs Forum; 2011 Nov; 38(6):699-708. PubMed ID: 22037332
[TBL] [Abstract][Full Text] [Related]
6. Qualitative exploration of healthcare relationships following delayed diagnosis of ovarian cancer and subsequent participation in supportive-expressive group therapy.
Walker LM; Robinson JW
Oncol Nurs Forum; 2009 Nov; 36(6):E310-6. PubMed ID: 19887344
[TBL] [Abstract][Full Text] [Related]
7. Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.
Zilliacus E; Meiser B; Gleeson M; Watts K; Tucker K; Lobb EA; Mitchell G
Support Care Cancer; 2012 Nov; 20(11):2949-58. PubMed ID: 22441502
[TBL] [Abstract][Full Text] [Related]
8. In the moment: women speak about surgical treatment decision making days after a breast cancer diagnosis.
Lally RM
Oncol Nurs Forum; 2009 Sep; 36(5):E257-65. PubMed ID: 19726385
[TBL] [Abstract][Full Text] [Related]
9. An exploration of the patient navigator role: perspectives of younger women with breast cancer.
Pedersen AE; Hack TF; McClement SE; Taylor-Brown J
Oncol Nurs Forum; 2014 Jan; 41(1):77-88. PubMed ID: 24368241
[TBL] [Abstract][Full Text] [Related]
10. Patient perspectives on the usefulness of routine telephone follow-up as psychosocial support for hematologic malignancies: Australian findings.
McGrath P
Oncol Nurs Forum; 2014 Jan; 41(1):40-4. PubMed ID: 24368238
[TBL] [Abstract][Full Text] [Related]
11. Information needs, sources of information, and decisional roles in women with breast cancer.
Bilodeau BA; Degner LF
Oncol Nurs Forum; 1996 May; 23(4):691-6. PubMed ID: 8735327
[TBL] [Abstract][Full Text] [Related]
12. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
[TBL] [Abstract][Full Text] [Related]
13. Instrumental relating and treatment decision making among older women with early-stage breast cancer.
Pieters HC; Heilemann MV; Maliski S; Dornig K; Mentes J
Oncol Nurs Forum; 2012 Jan; 39(1):E10-9. PubMed ID: 22201664
[TBL] [Abstract][Full Text] [Related]
14. Signs of aging or the vague symptoms of ovarian cancer?
Smith A; Rocconi RP; Finan MA
Oncol Nurs Forum; 2012 Mar; 39(2):E150-6. PubMed ID: 22374503
[TBL] [Abstract][Full Text] [Related]
15. Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
Burcher S; Meiser B; Mitchell G; Saunders C; Rahman B; Tucker K; Barlow-Stewart K; Watts K; Gleeson M; Kirk J
Per Med; 2013 Jul; 10(5):431-440. PubMed ID: 29758836
[TBL] [Abstract][Full Text] [Related]
16. "Cautiously optimistic that today will be another day with my disease under control": understanding women's lived experiences of ovarian cancer.
Burles M; Holtslander L
Cancer Nurs; 2013; 36(6):436-44. PubMed ID: 23348660
[TBL] [Abstract][Full Text] [Related]
17. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
Brain K; Gravell C; France E; Fiander A; Gray J
Gynecol Oncol; 2004 Mar; 92(3):905-13. PubMed ID: 14984959
[TBL] [Abstract][Full Text] [Related]
18. Women with newly diagnosed breast cancer and their perceptions of needs in a health-care context.
Landmark BT; Bøhler A; Loberg K; Wahl AK
J Clin Nurs; 2008 Apr; 17(7B):192-200. PubMed ID: 18578795
[TBL] [Abstract][Full Text] [Related]
19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
20. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
